In silico drug discovery made easy
We use Big Data and Artificial Intelligence to
accelerate your novel Drug Development through:
Our very easy to use SaaS platform provides a versatile set of applications to facilitate target identification and elucidate the mechanisms of action (MoA).
From in silico Drug Design to computational prediction of ADME and pharmacokinetics.
Elucidate the Mode of Action (MoA) of specific molecules and rationalize their off-target effects.
In silico screening of libraries, hit & lead expansion and drug repurposing.
Identify and characterize binding sites using Artificial Intelligence approaches.
Mind the Byte CEO and founder, Alfons Nonell-Canals, has been chosen as one of three finalists vying for the 2017 Young Entrepreneur Award awarded by the Independent Association of Young Entrepreneurs of Catalonia (AIJEC). The other finalists are Gerard...
A new version of our SaaS platform for computational drug discovery was released last week. This scheduled update includes several enhanced features like improved algorithms or a new visualization 3D engine. In this regard, all the applications now have a...
We are pleased to announce the Bio-IT has selected Mind the Byte as one of the 2018 Best of Show finalists. The Best of Show Awards offers exhibitors at the Bio-IT World Conference & Expo an opportunity to showcase their new products. A team of expert...